GlaxoSmithKline (GSK) has successfully divested its entire remaining stake in consumer healthcare firm Haleon, securing proceeds of 1.25 billion pounds ($1.52 b



GSK Completes Sale of Haleon Stake for £1.25 Billion


blog post cover photo

Image credit: Jamie Street

GlaxoSmithKline (GSK) has successfully divested its entire remaining stake in consumer healthcare firm Haleon, securing proceeds of 1.25 billion pounds ($1.52 billion), the British pharmaceutical company announced on Friday.

In the transaction, GSK sold approximately 385 million shares at a price of 324 pence per share, representing a 4.2% stake in Haleon. The consumer healthcare firm was established through the merger of GSK and Pfizer's consumer healthcare businesses in 2019.

The sale was executed at a slight discount of approximately 2.5% to Haleon's closing price of 332.4 pence on Thursday.

This move aligns with GSK's strategic focus on its core areas, particularly vaccines, cancer, and infectious diseases, which CEO Emma Walmsley has prioritized to enhance earnings under the current company strategy.

Initially holding nearly a 13% stake in Haleon, GSK had spun out and listed the consumer healthcare entity on the London Stock Exchange in July 2022.

Notably, this divestment represents GSK's fourth sale of its interest in the Sensodyne toothpaste maker within just over a year.

Find out more about GSK's financial score with Financial Score API.

Other Blogs

Nov 25, 2023 6:39 AM - Parth Sanghvi

DCF Valuation vs. Comparable Companies Analysis: Choosing the Right Valuation Method

Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...

blog post title

Dec 23, 2023 2:19 AM - Parth Sanghvi

Understanding the Limitations of DCF Analysis: A Guide to Overcoming Challenges

Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...

blog post title

Dec 25, 2023 2:28 AM - Parth Sanghvi

Integrating Sustainability into Valuations: Navigating ESG Factors within the Discounted Cash Flow (DCF) Model

Introduction: The investment landscape is undergoing a profound shift with a heightened emphasis on sustainability and responsible investing. In this blog post, we explore the intersection of Environmental, Social, and Governance (ESG) considerations within the Discounted Cash Flow (DCF) model, h...

blog post title


Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
2017-2024 © Financial Modeling Prep